Market Update Graphic
Source: The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Christmas is fast approaching and the ASX200 has been down 0.35% at 8,267 points. The Santa rally has so far failed to materialise as the latest round of Chinese stimulus underwhelmed investors.

The Iron Ore price is steady at around US$103.75 per tonne in Singapore after sliding on the weekend.

Materials has been the poorest performing sector, down 1.6%, followed by IT and Real Estate, both down around 0.65%.

Utilities has been the best, up 0.3%, followed by Industrials and Financials, up 0.2%.

Company News

Online retailer Kogan (ASX:KGN) has been down 1% on the news ASIC is investigating a potentially controversial options deal involving two of its senior executives, including founder Ruslan Kogan. The deal netted $17 million in profits for the executives and the company is cooperating with the investigation.

Kogan has been $5.60.

Fortescue (ASX:FMG) has been down 2.4% as analysts at Bell Potter retain their Sell rating saying it’s ‘hard to see the upside.’ The broker notes certain high-grade ores which are more carbon efficient may encounter specific tailwinds in the new year.

Fortescue has been $18.81.

Invex Therapeutics (ASX:IXC) has had success simulating the use of Exenatide to improve cell survival in a 3D ‘human brain model’ of Alzheimer’s disease.

Invex Therapeutics has been 7.4 cents.

More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.